66 related articles for article (PubMed ID: 22147656)
41. Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.
Chen WG; Zhou TT; Zhou P; Li XW; Wu Z; Zhang KY; Xing JC
Int J Clin Exp Pathol; 2015; 8(6):6901-9. PubMed ID: 26261577
[TBL] [Abstract][Full Text] [Related]
42. Vascular aldosterone production at the pre-diabetic stage of young Otsuka Long-Evans Tokushima Fatty (OLETF) rats, compared with Long-Evans Tokushima Otsuka (LETO) rats.
Matsuzawa Y; Suematsu S; Saito J; Omura M; Nishikawa T
Molecules; 2013 Dec; 18(12):15636-47. PubMed ID: 24352019
[TBL] [Abstract][Full Text] [Related]
43. Stimulation of phagocyte adhesion to endothelial cells by modified VLDL and HDL requires scavenger receptor BI.
Saha S; Graessler J; Bornstein SR; Schwarz PE; Kopprasch S
Mol Cell Biochem; 2013 Nov; 383(1-2):21-8. PubMed ID: 23852455
[TBL] [Abstract][Full Text] [Related]
44. Very-low-density lipoprotein mediates transcriptional regulation of aldosterone synthase in human adrenocortical cells through multiple signaling pathways.
Saha S; Bornstein SR; Graessler J; Kopprasch S
Cell Tissue Res; 2012 Apr; 348(1):71-80. PubMed ID: 22331364
[TBL] [Abstract][Full Text] [Related]
45. Crosstalk Between Glycoxidative Modification of Low-Density Lipoprotein, Angiotensin II-Sensitization, and Adrenocortical Aldosterone Release.
Saha S; Bornstein SR; Graessler J; Kopprasch S
Horm Metab Res; 2015 Oct; 47(11):855-60. PubMed ID: 25602349
[TBL] [Abstract][Full Text] [Related]
46. Prediabetic and diabetic in vivo modification of circulating low-density lipoprotein attenuates its stimulatory effect on adrenal aldosterone and cortisol secretion.
Kopprasch S; Pietzsch J; Ansurudeen I; Graessler J; Krug AW; Ehrhart-Bornstein M; Bornstein SR
J Endocrinol; 2009 Jan; 200(1):45-52. PubMed ID: 18835979
[TBL] [Abstract][Full Text] [Related]
47. [Not Available].
Saha S; Bornstein SR; Graessler J; Chakrabarti S; Kopprasch S
Horm Metab Res; 2017 Sep; 49(9):716-718. PubMed ID: 28834964
[TBL] [Abstract][Full Text] [Related]
48. Regulation of adrenal aldosterone production by serine protease prostasin.
Ko T; Kakizoe Y; Wakida N; Hayata M; Uchimura K; Shiraishi N; Miyoshi T; Adachi M; Aritomi S; Konda T; Tomita K; Kitamura K
J Biomed Biotechnol; 2010; 2010():793843. PubMed ID: 20204133
[TBL] [Abstract][Full Text] [Related]
49. Diabetic lipoproteins and adrenal aldosterone synthesis--a possible pathophysiological link?
Saha S; Willenberg HS; Bornstein SR; Graessler J; Kopprasch S
Horm Metab Res; 2012 Mar; 44(3):239-44. PubMed ID: 22147656
[TBL] [Abstract][Full Text] [Related]
50. Aldosterone biosynthesis in the human adrenal cortex and associated disorders.
Nakamura Y; Yamazaki Y; Konosu-Fukaya S; Ise K; Satoh F; Sasano H
J Steroid Biochem Mol Biol; 2015 Sep; 153():57-62. PubMed ID: 26051166
[TBL] [Abstract][Full Text] [Related]
51. Very low-density lipoprotein (VLDL)-induced signals mediating aldosterone production.
Tsai YY; Rainey WE; Bollag WB
J Endocrinol; 2017 Feb; 232(2):R115-R129. PubMed ID: 27913572
[TBL] [Abstract][Full Text] [Related]
52. Aging and Adrenal Aldosterone Production.
Nanba K; Vaidya A; Rainey WE
Hypertension; 2018 Feb; 71(2):218-223. PubMed ID: 29229745
[No Abstract] [Full Text] [Related]
53. Adrenal histopathology in primary aldosteronism: is it time for a change?
Gioco F; Seccia TM; Gomez-Sanchez EP; Rossi GP; Gomez-Sanchez CE
Hypertension; 2015 Oct; 66(4):724-30. PubMed ID: 26238443
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
